共 50 条
- [41] Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 TrialCLINICAL CANCER RESEARCH, 2021, 27 (15) : 4160 - 4167Subbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas, MD Anderson Canc Ctr, Houston, TX USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAGainor, Justin F.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAOxnard, Geoffrey R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USATan, Daniel S. W.论文数: 0 引用数: 0 h-index: 0机构: Duke NUS Med Sch, Natl Canc Ctr Singapore, Singapore, Singapore Univ Texas, MD Anderson Canc Ctr, Houston, TX USAOwen, Dwight H.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USACho, Byoung Chul论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea Univ Texas, MD Anderson Canc Ctr, Houston, TX USALoong, Herbert H.论文数: 0 引用数: 0 h-index: 0机构: Chinese Univ Hong Kong, Hong Kong, Peoples R China Univ Texas, MD Anderson Canc Ctr, Houston, TX USAMccoach, Caroline E.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAWeiss, Jared论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Chapel Hill, NC USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAKim, Yu Jung论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Bundang Hosp, Coll Med, Seongnam, Gyeonggi Do, South Korea Univ Texas, MD Anderson Canc Ctr, Houston, TX USABazhenova, Lyudmila论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, San Diego Moores Canc Ctr, San Diego, CA USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USA论文数: 引用数: h-index:机构:Daga, Haruko论文数: 0 引用数: 0 h-index: 0机构: Osaka City Gen Hosp, Osaka, Japan Univ Texas, MD Anderson Canc Ctr, Houston, TX USABesse, Benjamin论文数: 0 引用数: 0 h-index: 0机构: Inst Gustav Roussy, Villejuif, France Paris Saclay Univ, Orsay, France Univ Texas, MD Anderson Canc Ctr, Houston, TX USAGautschi, Oliver论文数: 0 引用数: 0 h-index: 0机构: Univ Bern, Luzern, Switzerland Cantonal Hosp Lucerne, Luzern, Switzerland Univ Texas, MD Anderson Canc Ctr, Houston, TX USARolfo, Christian论文数: 0 引用数: 0 h-index: 0机构: Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD USA Ctr Thorac Oncol, Tisch Canc Inst, Mt Sinai Med Syst, Ichan Sch Med, Mt Sinai, NY USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAZhu, Edward Y.论文数: 0 引用数: 0 h-index: 0机构: Loxo Oncol, Eli Lilly & Co, Indianapolis, IN USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAKherani, Jennifer F.论文数: 0 引用数: 0 h-index: 0机构: Loxo Oncol, Eli Lilly & Co, Indianapolis, IN USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAHuang, Xin论文数: 0 引用数: 0 h-index: 0机构: Loxo Oncol, Eli Lilly & Co, Indianapolis, IN USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USAKang, Suhyun论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USADrilon, Alexander论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Weill Cornell Med Coll, New York, NY USA Univ Texas, MD Anderson Canc Ctr, Houston, TX USA
- [42] Selpercatinib Striking Response in a Case of Cerebral and Auditory Canal Metastasis of RET Fusion-Positive Non-Small-Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S413 - S414Sousa, D.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalAfonso, M.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalRocha, D.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalCraveiro, A.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalMartins, S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalBarata, J.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, PortugalValente, M. L. S.论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Cova Da Beira, Covilha, Portugal Ctr Hosp Univ Cova Da Beira, Covilha, Portugal
- [43] Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC).JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Drilon, Alexander E.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAGautschi, Oliver论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USABesse, Benjamin论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASubbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USATan, Daniel Shao-Weng论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAPark, Keunchil论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USADe Braud, Filippo G.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAAlonso, Guzman论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAWolf, Juergen论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASoldatenkova, Victoria论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAFrench, Pearl Plernjit论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USALin, Aimee K.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USAGoto, Koichi论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USASolomon, Benjamin J.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
- [44] Alectinib shows potent antitumor activity against both ALK- and RET-rearranged non-small cell lung cancersCANCER RESEARCH, 2015, 75Kodama, Tatsushi论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanTsukaguchi, Toshiyuki论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanSatoh, Yasuko论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanYoshida, Miyuki论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanWatanabe, Yoshiaki论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanKondoh, Osamu论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, JapanSakamoto, Hiroshi论文数: 0 引用数: 0 h-index: 0机构: Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan Chugai Pharmaceut Co Ltd, Yokohama, Kanagawa, Japan
- [45] TREATMENT PATTERNS AND OUTCOMES OF RET FUSIONPOSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH SELPERCATINIB IN EUROPE: INTERIM RESULTS FROM THE SPRINT-RET STUDYVALUE IN HEALTH, 2024, 27 (12) : S582 - S582Popat, S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden NHS Fdn Trust, London, England Royal Marsden NHS Fdn Trust, London, EnglandHochmair, M.论文数: 0 引用数: 0 h-index: 0机构: Klin Floridsdorf, Karl Landsteiner Inst Lung Res & Pulm Oncol, Vienna, Austria Royal Marsden NHS Fdn Trust, London, EnglandGastaldo, Sanchez A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Virgen del Rocio, Seville, Spain Royal Marsden NHS Fdn Trust, London, EnglandHashemi, S.论文数: 0 引用数: 0 h-index: 0机构: Amsterdam UMC, Amsterdam, Netherlands Royal Marsden NHS Fdn Trust, London, EnglandPuri, T.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Royal Marsden NHS Fdn Trust, London, EnglandKhanal, M.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Indianapolis, IN 46285 USA Royal Marsden NHS Fdn Trust, London, EnglandPedros, M.论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Barcelona, Spain Royal Marsden NHS Fdn Trust, London, EnglandCuadras, D.论文数: 0 引用数: 0 h-index: 0机构: IQVIA, Barcelona, Spain Royal Marsden NHS Fdn Trust, London, EnglandSegall, G.论文数: 0 引用数: 0 h-index: 0机构: Eli Lilly & Co, Gerrards Cross, England Royal Marsden NHS Fdn Trust, London, England
- [46] Safety of alectinib in non-small cell lung cancer patients with RET fusion gene (ALL-RET): Results from the dose-finding portion of a phase 1/2 studyANNALS OF ONCOLOGY, 2017, 28Nosaki, K.论文数: 0 引用数: 0 h-index: 0机构: Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanTakeuchi, S.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ, Div Med Oncol, Canc Res Inst, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanTakahara, S.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanKawakami, T.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanYoh, K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanKono, Y.论文数: 0 引用数: 0 h-index: 0机构: Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanHoriike, A.论文数: 0 引用数: 0 h-index: 0机构: JFCR, Dept Thorac Med Oncol, Canc Inst Hosp, Tokyo, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanSeto, T.论文数: 0 引用数: 0 h-index: 0机构: Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanGoto, K.论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanYoshimura, K.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanImai, Y.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanMurayama, T.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ Hosp, Innovat Clin Res Ctr iCREK, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, JapanYano, S.论文数: 0 引用数: 0 h-index: 0机构: Kanazawa Univ, Div Med Oncol, Canc Res Inst, Kanazawa, Ishikawa, Japan Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan
- [47] Genetic profiling and the response to RET inhibitors in RET fusion positive non-small cell lung cancer (NSCLC) identified by international genomic screening project (LC-SCRUM-Asia).JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Nosaki, Kaname论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanMatsumoto, Shingo论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanYoh, Kiyotaka论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanIkeda, Takaya论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanOhe, Yuichiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanKodani, Masahiro论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanYanagitani, Noriko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanNishino, Kazumi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanShingyoji, Masato论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanTakeuchi, Shinji论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanZenke, Yoshitaka论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanUdagawa, Hibiki论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanKirita, Keisuke论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanNiho, Seiji论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, JapanGoto, Koichi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
- [48] Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access programTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13Illini, Oliver论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaHochmair, Maximilian Johannes论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaFabikan, Hannah论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Klin Floridsdorf, Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaWeinlinger, Christoph论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Klin Floridsdorf, Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaTufman, Amanda论文数: 0 引用数: 0 h-index: 0机构: LMU Munchen, Klinikum Univ Muenchen, Med Klin & Poliklin, Mitglied Deutsch Zentrums Lungenforsch, CPC M, Munich, Bayern, Germany Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaSwalduz, Aurelie论文数: 0 引用数: 0 h-index: 0机构: Ctr Leon Berard, Lyon, France Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaLamberg, Kristina论文数: 0 引用数: 0 h-index: 0机构: Uppsala Univ Hosp, Dept Pulm & Allerg Dis, Uppsala, Sweden Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaHashemi, Sayed M. S.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam, Med Ctr, Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaHuemer, Florian论文数: 0 引用数: 0 h-index: 0机构: Ludwig Boltzmann Inst Lung Hlth, Dept Resp Care, Klin Penzing, Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaVikstrom, Anders论文数: 0 引用数: 0 h-index: 0机构: Linkoping Univ Hosp, Pulm clin, Linkoping, Sweden Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaWermke, Martin论文数: 0 引用数: 0 h-index: 0机构: Tech Univ Dresden, Med Fac C G Carus, NCT UCC Early Clin Trial, Unit Dresden, Dresden, Germany Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaAbsenger, Gudrun论文数: 0 引用数: 0 h-index: 0机构: Med Univ Graz, Dept Oncol, Graz, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaAddeo, Alfredo论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Geneva, Oncol Dept, Geneva, Switzerland Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaBanerji, Shantanu论文数: 0 引用数: 0 h-index: 0机构: Univ Manitoba, Res Inst Oncol & Hematol, Canc Care Manitoba, Winnipeg, MB, Canada Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaCalles, Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Gregorio Maranon, Hosp Gen, Med Oncol Dept, Madrid, Spain Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaClarke, Stephen论文数: 0 引用数: 0 h-index: 0机构: Royal North Shore Hosp, Med Oncol Unit, St Leonards, NSW, Australia Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaDi Maio, Massimo论文数: 0 引用数: 0 h-index: 0机构: Univ Turin, Dept Oncol, Turin, Italy Ordine Mauriziano Hosp, Med Oncol, Turin, Italy Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaDurand, Alice论文数: 0 引用数: 0 h-index: 0机构: Univ Lyon, France Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Canc Inst Lyon,Louis Pradel Hosp,Resp Dept, Lyon, France Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaDuruisseaux, Michael论文数: 0 引用数: 0 h-index: 0机构: Hosp Civils Lyon, Canc Inst, Louis Pradel Hosp, Resp Dept, Lyon, France Canc Res Ctr Lyon, Oncopharmacol Lab, Lyon, France Univ Lyon, Univ Claude Bernard Lyon 1, Lyon, France Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaItchins, Malinda论文数: 0 引用数: 0 h-index: 0机构: Royal North Shore Hosp, Med Oncol Unit, St Leonards, NSW, Australia Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaKaaranien, Okko-Sakari论文数: 0 引用数: 0 h-index: 0机构: Kuopio Univ Hosp, Ctr Canc, Kuopio, Finland Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaKrenn, Florian论文数: 0 引用数: 0 h-index: 0机构: LKH Hochsteiermark Standort Leoben, Abt Lungenkrankheiten, Leoben, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaLaack, Eckart论文数: 0 引用数: 0 h-index: 0机构: Studiengesellschaft Hamatoonkol Hamburg, Hamburg, Germany Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, Austriade Langen, Adrianus Johannes论文数: 0 引用数: 0 h-index: 0机构: Netherlands Canc Inst, Amsterdam, Netherlands Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaMohorcic, Katja论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Goln, Med Oncol Unit, Golnik, Slovenia Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaPall, Georg论文数: 0 引用数: 0 h-index: 0机构: Univ Innsbruck Hosp, Dept Internal Med V Hematol Oncol, Innsbruck, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaPassaro, Antonio论文数: 0 引用数: 0 h-index: 0机构: European Inst Oncol IRCCS, Div Thorac Oncol, Milan, Italy Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaPrager, Gerald论文数: 0 引用数: 0 h-index: 0机构: Comprehens Canc Ctr Vienna, Dept Med I, Vienna, Austria Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaRittmeyer, Achim论文数: 0 引用数: 0 h-index: 0机构: LKI Lungenfachklin Immenhausen, Dept Thorac Oncol, Immenhausen, Germany Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaRothenstein, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaSchumacher, Michael论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaWoell, Ewald论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, AustriaValipour, Arschang论文数: 0 引用数: 0 h-index: 0机构: Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Klin Floridsdorf, Brunner Str 68, A-1210 Vienna, Austria
- [49] RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancerJournal of Translational Medicine, 20Chunyue Wang论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineZhenlong Zhang论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineYulan Sun论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineSong Wang论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineMengmeng Wu论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineQiuxiang Ou论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineYang Xu论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineZhiming Chen论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineYang Shao论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicineHong Liu论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of MedicinePeifeng Hou论文数: 0 引用数: 0 h-index: 0机构: Xiamen University,Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Medicine
- [50] RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancerJOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)Wang, Chunyue论文数: 0 引用数: 0 h-index: 0机构: Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaZhang, Zhenlong论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Fujian Prov Hosp, Dept Thorac Surg, Shengli Clin Med Coll, Fuzhou 350001, Fujian, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaSun, Yulan论文数: 0 引用数: 0 h-index: 0机构: Shandong First Med Univ, Dept Internal Med Div, Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaWang, Song论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing 210032, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaWu, Mengmeng论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing 210032, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaOu, Qiuxiang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing 210032, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaXu, Yang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing 210032, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaChen, Zhiming论文数: 0 引用数: 0 h-index: 0机构: Nantong Univ, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaShao, Yang论文数: 0 引用数: 0 h-index: 0机构: Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing 210032, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaLiu, Hong论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Dept Radiat Oncol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R ChinaHou, Peifeng论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Dept Med Oncol, Union Hosp, Fuzhou 350001, Fujian, Peoples R China Xiamen Univ, Affiliated Hosp 1, Sch Med, Dept Med Oncol,Xiamen Key Lab Antitumor Drug Tran, Xiamen 361013, Fujian, Peoples R China